We can provide your patients with educational resources related to access and support including co-pay information, disease education, and insurance coverage changes.
Patient counselors are just a phone call away to answer your patients’ questions and help them navigate through the various offerings of the support program.
Looking for ways to help patients access their medication? Let us help. We can provide information about other financial assistance that may be available for eligible patients.
*Limitations apply. This offer is not valid under Medicare, Medicaid, or any other federal or state program, for cash-paying patients, or for Massachusetts residents. Patient pays first $10 co-pay on a 30-day supply, and the program will pay up to $10,630 per 30-day supply up to an annual max of $30,000. Novartis reserves the right to rescind, revoke, or amend this program without notice. For the most up-to-date terms and conditions, visit Terms and Conditions or call 1-866-GLEEVEC (453-3832).
*For more detailed study information, please see full Prescribing Information.
†Numbers indicate the range of percentages in 4 studies among patients with newly diagnosed Ph+ CML, patients in blast crisis, in accelerated phase, and in the chronic phase after failure of interferon-alpha therapy.